Total Payments
$7,357
2024 Payments
$190.92
Companies
18
Transactions
235
Medicare Patients
5,869
Medicare Billing
$771,065
Payment Breakdown by Category
Food & Beverage$5,973 (81.2%)
Travel$1,368 (18.6%)
Education$16.15 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,973 | 228 | 81.2% |
| Travel and Lodging | $1,368 | 5 | 18.6% |
| Education | $16.15 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $3,328 | 30 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,403 | 88 | $0 (2024) |
| Amgen Inc. | $1,237 | 31 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $294.97 | 19 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $253.38 | 19 | $0 (2021) |
| PFIZER INC. | $231.14 | 10 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $169.26 | 11 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $97.46 | 6 | $0 (2019) |
| Allergan Inc. | $79.63 | 6 | $0 (2019) |
| Amarin Pharma Inc. | $58.68 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $190.92 | 3 | Abbott Laboratories ($144.93) |
| 2023 | $235.26 | 6 | Abbott Laboratories ($135.41) |
| 2022 | $756.09 | 22 | Abbott Laboratories ($381.22) |
| 2021 | $379.19 | 18 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($281.02) |
| 2020 | $310.84 | 20 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($172.50) |
| 2019 | $893.69 | 55 | Amgen Inc. ($245.09) |
| 2018 | $1,344 | 49 | Amgen Inc. ($407.05) |
| 2017 | $3,248 | 62 | Abbott Laboratories ($2,299) |
All Payment Transactions
235 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $144.93 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/11/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $27.61 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.38 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/07/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $17.94 | General |
| Category: Cardiovascular | ||||||
| 10/13/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.41 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/21/2023 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $135.41 | General |
| Category: Cardiac Rhythm Management | ||||||
| 05/18/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.35 | General |
| Category: Cardiovascular | ||||||
| 03/07/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $23.97 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 01/11/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.18 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/14/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.32 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/28/2022 | Abbott Laboratories | GALLANT (Device) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Cardiac Rhythm Management | ||||||
| 11/09/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.82 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/12/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.38 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/15/2022 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $180.36 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/07/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.37 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/31/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/24/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.68 | General |
| Category: Cardiovascular | ||||||
| 07/13/2022 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $25.82 | General |
| Category: Medical Device | ||||||
| 06/29/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $4.80 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/23/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $63.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/22/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $22.60 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/15/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/25/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.68 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/27/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.54 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/30/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.23 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,561 | 2,630 | $895,788 | $191,376 |
| 2022 | 17 | 1,565 | 2,662 | $940,263 | $202,626 |
| 2021 | 15 | 1,341 | 2,391 | $854,456 | $185,123 |
| 2020 | 17 | 1,402 | 2,465 | $914,687 | $191,939 |
Total Patients
5,869
Total Services
10,148
Medicare Billing
$771,065
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 246 | 513 | $112,860 | $44,448 | 39.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 118 | 118 | $295,000 | $39,815 | 13.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 241 | 277 | $221,600 | $37,672 | 17.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 110 | 174 | $51,330 | $22,854 | 44.5% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 106 | 424 | $63,600 | $18,187 | 28.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 276 | 584 | $27,448 | $5,906 | 21.5% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 109 | 109 | $20,710 | $5,247 | 25.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $15,075 | $5,222 | 34.6% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 123 | 125 | $49,200 | $4,160 | 8.5% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 48 | 49 | $18,130 | $2,241 | 12.4% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 25 | 38 | $4,940 | $2,079 | 42.1% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 25 | 48 | $6,480 | $1,097 | 16.9% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 31 | 59 | $4,130 | $983.87 | 23.8% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Office | 2023 | 44 | 47 | $2,585 | $848.32 | 32.8% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2023 | 14 | 20 | $2,700 | $617.96 | 22.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 246 | 561 | $123,420 | $48,618 | 39.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 127 | 129 | $322,500 | $45,254 | 14.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 231 | 280 | $224,000 | $39,749 | 17.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 106 | 432 | $64,800 | $20,804 | 32.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 81 | 118 | $34,810 | $16,133 | 46.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 51 | 51 | $17,085 | $5,965 | 34.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 115 | 117 | $22,230 | $5,703 | 25.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 276 | 564 | $26,508 | $5,612 | 21.2% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2022 | 129 | 132 | $52,400 | $3,745 | 7.1% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2022 | 71 | 72 | $26,640 | $3,668 | 13.8% |
About Dr. Robert Ficula, D.O
Dr. Robert Ficula, D.O is a Nuclear Cardiology healthcare provider based in Red Oak, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/02/2011. The National Provider Identifier (NPI) number assigned to this provider is 1811265085.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Ficula, D.O has received a total of $7,357 in payments from pharmaceutical and medical device companies, with $190.92 received in 2024. These payments were reported across 235 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($5,973).
As a Medicare-enrolled provider, Ficula has provided services to 5,869 Medicare beneficiaries, totaling 10,148 services with total Medicare billing of $771,065. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Nuclear Cardiology
- Other Specialties Cardiovascular Disease
- Location Red Oak, TX
- Active Since 12/02/2011
- Last Updated 09/22/2022
- Taxonomy Code 207UN0901X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811265085
Products in Payments
- LifeVest (Device) $1,403
- Pacemakers (Device) $1,299
- Repatha (Biological) $952.97
- CRT-Ds (Device) $742.34
- AVEIR (Device) $460.70
- ELIQUIS (Drug) $346.32
- ENTRESTO (Drug) $294.97
- Corlanor (Drug) $279.95
- XARELTO (Drug) $253.38
- Quadra Allure MP RF CRT Pacemkr (Device) $193.79
- QUADRA ASSURA (Device) $183.47
- CRT-Ps (Device) $170.58
- Allure CRT Pacemaker (Device) $149.33
- BYSTOLIC (Drug) $79.63
- PRADAXA (Drug) $73.08
- Vascepa (Drug) $58.68
- Connectivity and Remote care (Device) $53.14
- BRILINTA (Drug) $52.69
- CHANTIX (Drug) $36.14
- ICDs (Device) $33.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.